AWH's logo.
Ticker Symbol: AWH

Aspira Women`s Health Inc

$2.47 - 17-07-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000926617

Company Profile

vermillion, inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases. the company’s initial in vitro diagnostic test, ova1®, was the first fda-cleared, protein-based in vitro diagnostic multivariate index assay, and represented a new class of software-based liquid biopsy in vitro diagnostics. in march 2016 vermillion received fda clearance for overa™, a second generation ova1 test with significantly improved specificity and ease of use.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 2835
Address: Suite 100
CEO: Valerie Palmieri
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $5.79
Change: $0.08 ( 1.40%)
Days Range: $5.52 - $6.01
Beta: 1.58
52wk. High: $9.60
52wk. Low: $2.31
Ytd. Change 17.46%
50 Day Moving Average: $5.23
200 Day Moving Average: $4.11
Shares Outstanding: 10198341


Market Cap: 5.9B
PE Ratio: -2.63
EPS (TTM): -2.2


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A